Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation
about
Conduction abnormalities and ventricular arrhythmogenesis: The roles of sodium channels and gap junctionsUnderuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in ItalyBleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study.Expression changes of ionic channels in early phase of cultured rat atrial myocytes induced by rapid pacing.Advanced chronic kidney disease in non-valvular atrial fibrillation: extending the utility of R2CHADS2 to patients with advanced renal failureCHADS(2) score is predictive of left atrial thrombus on precardioversion transesophageal echocardiography in atrial fibrillation.Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgeryTransferring Patients with Intracerebral Hemorrhage Does Not Increase In-Hospital Mortality.Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case.Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol.Effects of two kinds of radio frequency ablations on morphology and function of left atrium in patients with atrial fibrillation.Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent.Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.Should we test for CYP2C9 before initiating anticoagulant therapy in patients with atrial fibrillation?Future epidemic impact of atrial fibrillation and a new interventional strategy for stroke prophylaxis.Risk versus benefit of non-vitamin K dependent anticoagulants compared to warfarin for the management of atrial fibrillation in the elderly.Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials.WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation: a percutaneous-device delivery approach.Paroxysmal atrial fibrillation in cryptogenic stroke.Antithrombotic treatment in atrial fibrillation.Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial.Management of delayed suprachoriodal haemorrhage after intraocular surgery and trauma.Periprocedural anticoagulation for atrial fibrillation ablation.Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?Dual-chamber pacemakers as long-term telemetry devices: ready for prime-time in diagnosing unsuspected atrial fibrillation?Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
P2860
Q26769921-3154E916-422B-4B16-8FE7-CB4916C18407Q28212575-0E6AA541-E172-408C-B8EF-2846A7AA7229Q33841770-24A08088-6F4D-44E6-A840-96956EC9F953Q35001371-02572670-1F60-4ADA-87E2-569B6B86827BQ35207851-99DD6F09-8A1C-47ED-9995-5B9CAE4ED075Q35660120-E49E58F3-9523-434E-AE26-774FE6268EC6Q35662599-C3F4C5AF-01AB-4134-B556-C545AA827A44Q36088730-FB959E55-27B3-4690-88C2-C9677D80C136Q36101603-63897F1B-D73C-4870-857A-988C5868CAF1Q36258652-E65E2355-F88D-4FA7-BA51-AF9CDC32C8C1Q36493361-D942CDC2-8E59-4D63-8E1A-38036B99CF59Q36764028-9C6BC567-E618-4877-A9A0-1B006B744CDAQ37107710-B8D4909A-314A-4B1F-9492-D7D34E413D56Q37160370-5608CE1A-B6F6-4B05-80A8-69E1E685FB5DQ37859753-A2EDD3EE-A0BC-4C5A-BE21-FDB32FBFB26EQ38099570-67D9018C-8E57-425E-94E6-F807AB962E62Q39637963-DA427D51-0E5B-4F93-967B-A019F4CC48A0Q40179120-B0674D4B-CEE0-48E9-BBEC-38377FDA7FECQ41860594-587DCFB2-BD53-41BE-A7B0-CF6424CFCAB1Q41878910-4C50C9C1-A2F3-45B3-8794-A6CF47695E19Q45285359-4BD8C776-9701-4207-89AE-9B37EA8A59CBQ45957155-B59FDD56-B429-44F7-9AF7-FE5B43325CBFQ46745679-94F1E1D7-BD59-41A3-90A9-5FE7843BB856Q46787271-3114A12A-9F5C-45EC-8A36-2966811F5F56Q51120485-BBE03015-529B-4A0D-9A6B-EA04EC99E01DQ55369085-99768138-FF45-4F37-AD79-2C0D67947BCE
P2860
Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Comparing the guidelines: anti ...... ients with atrial fibrillation
@ast
Comparing the guidelines: anti ...... ients with atrial fibrillation
@en
Comparing the guidelines: anti ...... ients with atrial fibrillation
@nl
type
label
Comparing the guidelines: anti ...... ients with atrial fibrillation
@ast
Comparing the guidelines: anti ...... ients with atrial fibrillation
@en
Comparing the guidelines: anti ...... ients with atrial fibrillation
@nl
prefLabel
Comparing the guidelines: anti ...... ients with atrial fibrillation
@ast
Comparing the guidelines: anti ...... ients with atrial fibrillation
@en
Comparing the guidelines: anti ...... ients with atrial fibrillation
@nl
P921
P3181
P1476
Comparing the guidelines: anti ...... ients with atrial fibrillation
@en
P2093
Gregory W Albers
Stanley G Rockson
P304
P3181
P356
10.1016/J.JACC.2003.11.028
P407
P577
2004-03-17T00:00:00Z